Vicus Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.43M Sell
51,926
-1,030
-2% -$91.8K 0.33% 53
2025
Q4
$4.18M Sell
52,956
-1,049
-2% -$82.2K 0.31% 48
2025
Q3
$4.32M Sell
54,005
-1,187
-2% -$101K 0.33% 47
2025
Q2
$5.02M Sell
55,192
-10,677
-16% -$975K 0.42% 40
2025
Q1
$6.17M Sell
65,869
-5,814
-8% -$521K 0.57% 33
2024
Q4
$6.52M Sell
71,683
-9,930
-12% -$948K 0.58% 30
2024
Q3
$8.47M Sell
81,613
-38,487
-32% -$3.92M 0.75% 26
2024
Q2
$11.7M Sell
120,100
-12,268
-9% -$1.13M 1.05% 21
2024
Q1
$11.9M Sell
132,368
-35,582
-21% -$3.01M 1.09% 21
2023
Q4
$13.4M Sell
167,950
-14,014
-8% -$1.05M 1.35% 20
2023
Q3
$12.9M Sell
181,964
-29,270
-14% -$2.19M 1.36% 20
2023
Q2
$16.3M Sell
211,234
-17,561
-8% -$1.36M 1.69% 14
2023
Q1
$17.2M Sell
228,795
-520
-0.2% -$38.7K 1.85% 13
2022
Q4
$18.1M Buy
229,315
+2,278
+1% +$171K 2.05% 11
2022
Q3
$15.9M Sell
227,037
-2,577
-1% -$202K 1.88% 10
2022
Q2
$18.4M Sell
229,614
-3,090
-1% -$242K 2.08% 12
2022
Q1
$17.6M Buy
232,704
+214
+0.1% +$17K 1.77% 13
2021
Q4
$19.2M Buy
+232,490
New +$18.2M 1.96% 14
2021
Q2
Sell
-250,708
Closed -$19.8M 170
2021
Q1
$19.8M Buy
250,708
+2,258
+0.9% +$177K 2.35% 9
2020
Q4
$21.2M Buy
248,450
+40,163
+19% +$3.32M 2.62% 9
2020
Q3
$16.1M Buy
208,287
+2,810
+1% +$214K 2.28% 10
2020
Q2
$15.1M Sell
205,477
-3,083
-1% -$219K 2.29% 9
2020
Q1
$13.8M Sell
208,560
-7,750
-4% -$547K 2.58% 9
2019
Q4
$14.9M Sell
216,310
-1,978
-0.9% -$135K 2.26% 9
2019
Q3
$16M Sell
218,288
-7,235
-3% -$525K 2.23% 8
2019
Q2
$16.2M Buy
225,523
+18,254
+9% +$1.3M 2.27% 7
2019
Q1
$14.2M Buy
207,269
+7,331
+4% +$474K 2.25% 7
2018
Q4
$11.9M Sell
199,938
-2,887
-1% -$181K 2.12% 10
2018
Q3
$13.6M Buy
202,825
+3,257
+2% +$217K 2.18% 8
2018
Q2
$12.9M Buy
199,568
+62,032
+45% +$4.06M 2.13% 9
2018
Q1
$9.86M Buy
137,536
+4,011
+3% +$289K 1.7% 11
2017
Q4
$10.1M Sell
133,525
-4,582
-3% -$335K 1.76% 10
2017
Q3
$10.1M Buy
138,107
+17,240
+14% +$1.24M 1.94% 9
2017
Q2
$8.96M Buy
120,867
+53,518
+79% +$3.97M 1.83% 11
2017
Q1
$4.93M Buy
67,349
+38,316
+132% +$2.68M 1.06% 24
2016
Q4
$1.9M Sell
29,033
-2,412
-8% -$165K 0.42% 56
2016
Q3
$2.33M Sell
31,445
-1,042
-3% -$77K 0.53% 53
2016
Q2
$2.38M Buy
32,487
+2,838
+10% +$202K 0.58% 40
2016
Q1
$2.1M Sell
29,649
-142
-0.5% -$9.45K 0.47% 49
2015
Q4
$1.99M Buy
29,791
+1,292
+5% +$85.9K 0.5% 58
2015
Q3
$1.81M Buy
28,499
+5,370
+23% +$351K 0.48% 54
2015
Q2
$1.51M Sell
23,129
-93
-0.4% -$6.31K 0.39% 67
2015
Q1
$1.61K Buy
23,222
+1,036
+5% +$71.6K 0.31% 63
2014
Q4
$1.53M Buy
22,186
+1,706
+8% +$115K 0.44% 55
2014
Q3
$1.34M Buy
20,480
+565
+3% +$37.3K 0.44% 44
2014
Q2
$1.36M Buy
19,915
+191
+1% +$12.8K 0.44% 47
2014
Q1
$1.28M Buy
19,724
+147
+0.8% +$9.26K 0.43% 46
2013
Q4
$1.28M Buy
19,577
+530
+3% +$33.9K 0.48% 41
2013
Q3
$1.13M Sell
19,047
-34
-0.2% -$2.01K 0.49% 43
2013
Q2
$1.09M Buy
+19,081
New +$1.13M 0.5% 39

Other funds holding CL

Vicus Capital's CL Position: Q1 2026 in Review

Vicus Capital reduced its Colgate-Palmolive (CL) stake by 1.9% in Q1 2026, selling an estimated $91.8K and leaving 51,926 shares worth $4.43M. The position accounts for 0.33% of the portfolio, ranked #53.

Vicus Capital first reported a position in CL in Q2 2013 and has held it in 50 quarters since. The position peaked at $21.2M in Q4 2020. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Vicus Capital held 51,926 shares of Colgate-Palmolive worth $4.43M as of Q1 2026.
  • Vicus Capital sold 1,030 Colgate-Palmolive shares in Q1 2026, an estimated $91.8K.
  • Colgate-Palmolive made up 0.33% of Vicus Capital's portfolio in Q1 2026, its #53 holding.
  • Vicus Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 50 quarters since.
  • Vicus Capital's Colgate-Palmolive position peaked at $21.2M in Q4 2020.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.